In light of sobering statistics from the MHRA, WHO and others about the quality of temperature-controlled drugs and medicinal products arriving at global research sites, regulatory agencies and pharmaceutical companies alike are demanding that every party involved in the pharmaceutical supply chain conform to GxP guidelines. This article outlines the main precepts of GxP as it applies to the pharmaceutical transport industry and offers insight on securing the global CTM supply chain.